The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma
Hematological Oncology · 2023-08 · 41 (3) · 323-334
DOI: 10.1002/hon.3102 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hematological Oncology, online erschienen am 07.12.2022. Verfasst von Kelechi C Eseonu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St. Thomas' Hospitals, London, UK. Hauptthemen laut MEDLINE: Fractures, Compression, Spinal Fractures, Multiple Myeloma, Osteoporotic Fractures. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 90 Literaturangaben.
Abstract (Originalsprache)
Multiple myeloma (MM) is a systemic disorder characterised by proliferation of B‐lymphocytes and plasma cells in the bone marrow. The primary aims of the management of spinal lesions in MM are pain control and fracture stabilisation. Vertebral augmentation procedures (VAP) can be subdivided into percutaneous vertebroplasty (VP) and balloon kyphoplasty (BKP). BKP involves the placement of orthopaedic balloons into the fractured vertebral body, creating a void into which polymethylmethacrylate bone cement is injected. This review outlines the management of spinal lesions in patients with MM, with a focus on the comparative risks and efficacy of vertebroplasty (VP) and balloon kyphoplasty (BKP). Soft tissue masses in MM are highly radiosensitive. Bisphosphonates and newer oncological therapies have decreased the indications for palliative radiotherapy, while spinal bracing can be utilised in selected cases to provide stability. BKP and VP provide equivalent long term pain control after MM vertebral compression fractures (VCF). BKP is superior to non‐operative management and VP for restoration of vertebral body height and prevention of segmental kyphosis. Current evidence suggests a greater degree of correction of kyphotic deformity and restoration of mid vertebral height (MVH) with BKP when compared with VP. The literature supports the use of BKP even in the presence of posterior vertebral body wall (PVBW) fractures, a group previously considered a contraindication to VAP. Superior functional outcomes have been reported in patients undergoing early versus delayed BKP (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guy's and St. Thomas' Hospitals, London, UK.
- Yale New Haven Hospital, New Haven, Connecticut, USA.
ORCID-Profile: Kelechi C Eseonu
Zitieren
APA
Eseonu, K. C., Panchmatia, J. R., Streetly, M. J., Grauer, J. N., & Fakouri, B. (2023). The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma. Hematological Oncology, 41(3), 323-334. https://doi.org/10.1002/hon.3102
Vancouver
Eseonu KC, Panchmatia JR, Streetly MJ, Grauer JN, Fakouri B. The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma. Hematological Oncology. 2023;41(3):323-334. doi:10.1002/hon.3102
BibTeX
@article{Eseonu2023,
author = {Eseonu, Kelechi C and Panchmatia, Jaykar R and Streetly, Matthew J and Grauer, Jonathan N and Fakouri, Bahram},
title = {The role of Vertebral Augmentation Procedures in the management of vertebral compression fractures secondary to multiple myeloma},
journal = {Hematological Oncology},
year = {2023},
volume = {41},
number = {3},
pages = {323--334},
doi = {10.1002/hon.3102}
}
EUVIMED